6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis

被引:68
|
作者
Ocio, E. M.
Schop, R. F. J.
Gonzalez, B.
Van Wier, S. A.
Hernandez-Rivas, J. M.
Gutierrez, N. C.
Garcia-Sanz, R.
Moro, M. J.
Aguilera, C.
Hernandez, J.
Xu, R.
Greipp, P. R.
Dispenzieri, A.
Jalal, S. M.
Lacy, M. Q.
Gonzalez-Paz, N.
Gertz, M. A.
San Miguel, J. F.
Fonseca, R.
机构
[1] Hosp Univ Salamanca, Dept Hematol, Salamanca 37007, Spain
[2] Univ Salamanca, Dept Hematol, Ctr Invest Canc, E-37008 Salamanca, Spain
[3] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA
[4] Hosp Virgen Blanca Leon, Dept Hematol, Leon, Spain
[5] Hosp Gen Segovia, Dept Hematol, Segovia, Spain
关键词
DNA deletions; Waldenstrom macroglobulinemia; fluorescence in situ hybridisation; prognostic; 6q deletion;
D O I
10.1111/j.1365-2141.2006.06389.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluorescence in situ hybridisation (FISH) is an effective technique for the cytogenetic analysis of Waldenstrom macroglobulinemia (WM), but the potential impact of molecular cytogenetics on disease evolution and as a prognostic marker is still unknown. Deletion of the long arm of chromosome 6 (6q-) is the most frequent cytogenetic abnormality in WM. This study analysed the prevalence of this aberration in 102 WM patients, and correlated it with disease characteristics. The incidence of 6q21 deletion was 7% by conventional cytogenetics and 34% when analysed by FISH (54% when cytoplasmic immunoglobulin M-FISH was used). Patients with deletion of 6q displayed features of adverse prognosis, such as higher levels of beta 2-microglobulin and monoclonal paraprotein and a greater tendency to display anaemia and hypoalbuminemia. Interestingly, there was a correlation between the presence of 6q deletion and the International Staging System prognostic index (incidence of 6q- among patients stratified in stages 1, 2 and 3 was 24%, 42% and 67% respectively). Those patients diagnosed with smouldering WM who displayed the abnormality showed a trend to an earlier requirement of treatment. Finally, the survival analysis did not show differences between the two groups of patients, probably due to the short
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [31] Interstitial deletion of 20q in a patient with Waldenstrom macroglobulinemia following chemotherapy
    Blann, MM
    Velagaleti, GVN
    Morgan, DL
    Martinez, RE
    Conlin, PA
    Tonk, VS
    CANCER GENETICS AND CYTOGENETICS, 2002, 132 (02) : 145 - 148
  • [32] Haploinsufficiency of the Gene Quaking (QKI) Is Associated With the 6q Terminal Deletion Syndrome
    Backx, Liesbeth
    Fryns, Jean-Pierre
    Marcelis, Carlo
    Devriendt, Koen
    Vermeesch, Joris
    Van Esch, Hilde
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (02) : 319 - 326
  • [33] Large deletion in 6q associated to A20 haploinsufficiency and thoracoabdominal heterotaxy
    Viel, Sebastien
    Cheyssac, Elodie
    Pescarmona, Remi
    Besson, Laurie
    Till, Marianne
    Viremouneix, Loic
    Touitou, Isabelle
    Sarrabay, Guillaume
    Walzer, Thierry
    Belot, Alexandre
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1696 - 1698
  • [34] Chromosome 6Q deletion pattern in malignant lymphomas
    Tibiletti, M
    Taborelli, M
    Martin, V
    Pozzi, B
    Chini, C
    Bertoni, F
    Capella, C
    ANNALS OF ONCOLOGY, 2005, 16 : 142 - 143
  • [35] Isolated deletion of 6q in a patient with myelodysplastic syndrome
    Gozzetti, Alessandro
    Crupi, Rosaria
    Defina, Marzia
    Bocchia, Monica
    Raspadori, Donatella
    Lauria, Francesco
    CANCER GENETICS AND CYTOGENETICS, 2009, 192 (01) : 51 - 51
  • [36] Proximal interstitial 6q deletion: A recognizable syndrome
    Kumar, R
    Riordan, D
    Dawson, AJ
    Chudley, AE
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 71 (03): : 353 - 356
  • [37] Chronic lymphocytic leukemia with 6q− shows distinct hematological features and intermediate prognosis
    A Cuneo
    G M Rigolin
    R Bigoni
    C De Angeli
    A Veronese
    F Cavazzini
    A Bardi
    M G Roberti
    E Tammiso
    P Agostini
    M Ciccone
    M Della Porta
    A Tieghi
    L Cavazzini
    M Negrini
    G Castoldi
    Leukemia, 2004, 18 : 476 - 483
  • [38] Interstitial deletion of 6q without phenotypic effect
    Hansson, Kerstin
    Szuhai, Karoly
    Knijnenburg, Jeroen
    van Haeringen, Arie
    de Pater, Joke
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (12) : 1354 - 1357
  • [39] CUTANEOUS AND JOINT LAXITY IN CHROMOSOME 6Q DELETION
    DILERNIA, V
    ALBERTINI, G
    PEDIATRIC DERMATOLOGY, 1994, 11 (03) : 281 - 282
  • [40] DELETION OF 6Q IN 8 PRIMARY LUNG ADENOCARCINOMAS
    LIU, CX
    LI, P
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 244 - 244